Patent · US Active

Prodrugs of 2,4-pyrimidinediamine compounds and their uses

US7989448B2 · kind B2 · utility

28Cited by

51References

20Claims

0Family size

Assignee

Rigel Pharmaceuticals, Inc. · US

Inventors

Rajinder Singh · Belmont, US
Somasekhar Bhamidipati · Foster City, US
Esteban Masuda · Menlo Park, US

Key dates

Filing date	Nov 10, 2008
Grant date	Aug 2, 2011
Priority date	—
Expiry date	Apr 3, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07F9/65742
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure provides compounds of the following formula,and methods of using the compounds to inhibit cellular degranulation and to treat diseases associated therewith.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.